FindTrial
Sign In

Relationship of serum LDH With fetomaternal outcome in pre eclampsia

Association of serum lactate dehydrogenase with fetomaternal outcome in pre eclampsia- A cross sectional study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/03/064832
Enrollment
147
Registered
2024-03-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O149- Unspecified pre-eclampsia

Interventions

Control Intervention1: Nil: Nil

Sponsors

Department of obstetric and gynaecology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Singelton pregnancy. 2.Pregnant women at more than 28 weeks of period till term of gestation. 3.Women willing for our participation as per protocol.

Exclusion criteria

Exclusion criteria: 1.Patient with history of diabetes, renal disease, chronic hypertension, liver disease, chronic lung disease, connective tissue disorders, seizure, DIC, stroke, smoking, alcoholism, any hepatotoxic drugs, thyroid disorder and UTI. 2.Patient with molar pregnancy, gestational diabetes mellitus.

Design outcomes

Primary

MeasureTime frame
Relationship of LDH in pre eclampsiaTimepoint: 1 year—

Secondary

MeasureTime frame
Maternal mortality, morbidity and fetal outcomeTimepoint: 1 year—

Countries

India

Contacts

Public ContactDR KHUSHBOO CHAURASIA

ROHILKHAND MEDICAL COLLEGE AND HOSPITAL

drlataagrawal.la@gmail.com9557033100

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026